UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Combined first-stage hepatectomy and colorectal resection in a two-stage hepatectomy strategy for bilobar synchronous liver metastases

British journal of surgery, 2010-09, Vol.97 (9), p.1354-1362

2010

Volltextzugriff (PDF)

Postoperative irinotecan in resected stage II–III rectal cancer: final analysis of the French R98 Intergroup trial

Annals of oncology, 2015-06, Vol.26 (6), p.1208-1215

2015

Volltextzugriff (PDF)

Phase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients (pts) over 70 with previously treated metastatic colorectal adenocarcinoma (mCRC) FFCD 1404 - REGOLD

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii156

2018

Volltextzugriff (PDF)

Chemotherapy Has Also an Effect on Primary Tumor in Colon Carcinoma

Annals of surgical oncology, 2008-12, Vol.15 (12), p.3440-3446

2008

Volltextzugriff (PDF)

A phase III adjuvant randomised trial of 6 cycles of 5-fluorouracil–epirubicine–cyclophosphamide (FEC100 ) versus 4 FEC 100 followed by 4 Taxol (FEC-T) in node positive breast cancer patients (Trial B2000)

European journal of cancer (1990), 2014-01, Vol.50 (1), p.23-30

2014

Volltextzugriff (PDF)

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

The New England journal of medicine, 2011-05, Vol.364 (19), p.1817-1825

2011

Volltextzugriff (PDF)

Primary chemotherapy with or without colonic stent for management of irresectable stage IV colorectal cancer

European journal of surgical oncology, 2010-01, Vol.36 (1), p.58-64

2010

Volltextzugriff (PDF)

Safety, Pharmacokinetic, and Antitumor Activity of SU11248, a Novel Oral Multitarget Tyrosine Kinase Inhibitor, in Patients With Cancer

Journal of clinical oncology, 2006-01, Vol.24 (1), p.25-35

2006

Volltextzugriff (PDF)

Tumeurs phyllodes et sarcomes du sein : mise au point

Bulletin du cancer, 2010-10, Vol.97 (10), p.1197-1207

2010

Volltextzugriff (PDF)

Phyllodes tumors and breast sarcomas: a review

Bulletin du cancer, 2010-10, Vol.97 (10), p.1197

2010

Volltextzugriff (PDF)

Erratum à « Spécificités de la prise en charge par chimiothérapie chez le sujet âgé » [Prog Urol 2009;S3:S100–5]

Progrès en urologie (Paris), 2010-07, Vol.20 (7), p.545-545

2010

Volltextzugriff (PDF)

Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial

Journal of clinical oncology, 2023-10, Vol.41 (30), p.4768-4778

2023

Volltextzugriff (PDF)

Benefits of adding a drug to a single-agent or a 2-agent chemotherapy regimen in advanced non-small-cell lung cancer: a meta-analysis

JAMA : the journal of the American Medical Association, 2004-07, Vol.292 (4), p.470

2004

Volltextzugriff (PDF)

Spécificités de la prise en charge par chimiothérapie chez le sujet âgé

Progrès en urologie (Paris), 2009-11, Vol.19, p.S100-S105

2009

Volltextzugriff (PDF)

P28 Follow-up and 6-months outcome of elderly cancer patients after initial onco-geriatric assessment

Critical reviews in oncology/hematology, 2009, Vol.72 (1), p.S28-S29

2009

Volltextzugriff (PDF)

P29 Geriatric assessment in elderly cancer patients: geriatric syndromes and impact on treatment

Critical reviews in oncology/hematology, 2009, Vol.72 (1), p.S29-S29

2009

Volltextzugriff (PDF)

Abstract P6-03-06: Assessing occult brain metastasis with CT scan or MRI in HER2-positive breast cancer patients at initial diagnosis

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P6-P6-03-06

2018

Volltextzugriff (PDF)

Randomised, open-label, multicentric phase III trial to evaluate the safety and efficacy of palbociclib in combination with endocrine therapy, guided by ESR1 mutation monitoring in oestrogen receptor-positive, HER2-negative metastatic breast cancer patients: study design of PADA-1

BMJ open, 2022-03, Vol.12 (3), p.e055821-e055821

2022

Volltextzugriff (PDF)

Single-arm phase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients over 70 with previously treated metastatic colorectal adenocarcinoma FFCD 1404 – REGOLD

Journal of geriatric oncology, 2020-11, Vol.11 (8), p.1255-1262

2020

Volltextzugriff (PDF)

Early detection of recurrence by FDG-PET in the follow-up of patients with colorectal cancer

British journal of cancer, 2008-03, Vol.98 (5), p.875-880

2008

Volltextzugriff (PDF)

1023PUse of bevacizumab (Bev) in real life for first-line (fl) treatment of ovarian cancer (OC)/ The GINECO ENCOURAGE cohort of 500 French patients

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Use of bevacizumab (Bev) in real life for first-line (fl) treatment of ovarian cancer (OC)/ The GINECO ENCOURAGE cohort of 500 French patients

Annals of oncology, 2019-10, Vol.30, p.v418

2019

Volltextzugriff (PDF)

1023P - Use of bevacizumab (Bev) in real life for first-line (fl) treatment of ovarian cancer (OC)/ The GINECO ENCOURAGE cohort of 500 French patients

Annals of oncology, 2019-10, Vol.30, p.v418-v418

2019

Volltextzugriff (PDF)

466PPhase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients (pts) over 70 with previously treated metastatic colorectal adenocarcinoma (mCRC) FFCD 1404 - REGOLD

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(60)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(24)
Life Sciences & Biomedicine
(23)
Science & Technology
(23)
Biological And Medical Sciences
(16)
Medical Sciences
(16)
Oncology
(16)
Aged
(15)
Female
(14)
Middle Aged
(14)
Adult
(13)
Tumors
(13)
Male
(11)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(10)
Treatment Outcome
(7)
Gastroenterology. Liver. Pancreas. Abdomen
(6)
Hematology, Oncology And Palliative Medicine
(6)
Chemotherapy
(5)
Chemotherapy, Adjuvant
(5)
General & Internal Medicine
(5)
General Aspects
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Combined first-stage hepatectomy and colorectal resection in a two-stage hepatectomy strategy for bilobar synchronous liver metastases

Postoperative irinotecan in resected stage II–III rectal cancer: final analysis of the French R98 Intergroup trial

Phase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients (pts) over 70 with previously treated metastatic colorectal adenocarcinoma (mCRC) FFCD 1404 - REGOLD

Chemotherapy Has Also an Effect on Primary Tumor in Colon Carcinoma

Prognostic value of EndoPredict test in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative primary breast cancer screened for the randomized, double-blind, phase III UNIRAD trial

A phase III adjuvant randomised trial of 6 cycles of 5-fluorouracil–epirubicine–cyclophosphamide (FEC100 ) versus 4 FEC 100 followed by 4 Taxol (FEC-T) in node positive breast cancer patients (Trial B2000)

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

Primary chemotherapy with or without colonic stent for management of irresectable stage IV colorectal cancer

Safety, Pharmacokinetic, and Antitumor Activity of SU11248, a Novel Oral Multitarget Tyrosine Kinase Inhibitor, in Patients With Cancer

Tumeurs phyllodes et sarcomes du sein : mise au point

Phyllodes tumors and breast sarcomas: a review

Erratum à « Spécificités de la prise en charge par chimiothérapie chez le sujet âgé » [Prog Urol 2009;S3:S100–5]

Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial

Benefits of adding a drug to a single-agent or a 2-agent chemotherapy regimen in advanced non-small-cell lung cancer: a meta-analysis

Spécificités de la prise en charge par chimiothérapie chez le sujet âgé

P28 Follow-up and 6-months outcome of elderly cancer patients after initial onco-geriatric assessment

P29 Geriatric assessment in elderly cancer patients: geriatric syndromes and impact on treatment

Abstract P6-03-06: Assessing occult brain metastasis with CT scan or MRI in HER2-positive breast cancer patients at initial diagnosis

Randomised, open-label, multicentric phase III trial to evaluate the safety and efficacy of palbociclib in combination with endocrine therapy, guided by ESR1 mutation monitoring in oestrogen receptor-positive, HER2-negative metastatic breast cancer patients: study design of PADA-1

Single-arm phase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients over 70 with previously treated metastatic colorectal adenocarcinoma FFCD 1404 – REGOLD

Early detection of recurrence by FDG-PET in the follow-up of patients with colorectal cancer

1023PUse of bevacizumab (Bev) in real life for first-line (fl) treatment of ovarian cancer (OC)/ The GINECO ENCOURAGE cohort of 500 French patients

Use of bevacizumab (Bev) in real life for first-line (fl) treatment of ovarian cancer (OC)/ The GINECO ENCOURAGE cohort of 500 French patients

1023P - Use of bevacizumab (Bev) in real life for first-line (fl) treatment of ovarian cancer (OC)/ The GINECO ENCOURAGE cohort of 500 French patients

466PPhase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients (pts) over 70 with previously treated metastatic colorectal adenocarcinoma (mCRC) FFCD 1404 - REGOLD

Suchergebnisse filtern